Peptide Source Tracker

Umbrella Labs Review

umbrellalabs.is

Active — FDA warning letterSince 2021-05-18

Peptide Source Tracker is independent and not affiliated with Umbrella Labs.

Umbrella Labs is operating; it publishes a COA library and states third-party testing, and accepts card payments. The FDA sent Umbrella Labs a warning letter in May 2021 alleging unapproved-new-drug and misbranding claims involving SARMs. A warning letter is an allegation of violations, not a finding of guilt.

Published rubric

Scorecard

Documentationpublic COA library2/3
Testingthird-party testing stated2/3
Payment safetycard accepted3/3
Track recordagency warning letter1/3
Total score6.7out of 10

Documented history

Record

FDA warning letter alleging unapproved-new-drug and misbranding claims involving SARMs

FDA Warning Letter 612037 alleged that human-use marketing for SARMs sold through umbrellalabs.is supported unapproved-new-drug and misbranding violations despite research-use-only labeling.

Sources

Facts

Domainumbrellalabs.is
StatusActive — FDA warning letter
Last verified
TestingPublic product-category COAs; independent chemists stated, no commercial lab named
PaymentsCredit/debit cards, Bitcoin, ACH, and Zelle

From the operator

Compare against a fully documented vendor
Curo publishes a verifiable COA for every lot and takes card payment — see the documentation standard this tracker scores against.
See Curo's COAs

Related reviews

Swiss ChemsPure RawzPrime Peptides
Compare all vendors →